Veru Inc. (VERU) Stock Analysis
A live, multi-source view of Veru Inc. (VERU): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Veru Inc.
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Sector: Healthcare · Industry: Biotechnology · United States · 20 employees · verupharma.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Veru Inc. (VERU) had a market capitalization of $45.0M (forward -2.7) and a beta of -1.16; the shares traded in a 52-week range of $2.05 – $7.33 (-21.7% over the year).
- Market cap
- $45.0M
- Enterprise value
- $22.0M
- Forward P/E
- -2.7
- PEG ratio
- 3.60
- Price / book
- 1.59
- EPS (trailing)
- $-0.61
- EPS (forward)
- $-0.98
- Payout ratio
- 0.0%
- Ex-dividend date
- 2014-04-28
- 52-week range
- $2.05 – $7.33
- 52-week change
- -21.7%
- Beta
- -1.16
- Average volume
- 374,882
- Shares outstanding
- 17.1M
- Short % of float
- 9.07%
- Profit margin
- 0.0%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-10
In RapidTradeView’s 2026-09-10 scan of the US universe, Veru Inc. (VERU) last closed at $2.48 (the last completed close before that scan).
Technicals at the scan: RSI 43 (neutral territory), price -7.1% versus its 20-day average, 20-day versus 50-day average spread +3.9%, MACD histogram -0.02.
Sentiment inputs: StockTwits 100% bullish.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of VERU; corporate insiders filed 1 buy and 0 sells (1 filer, latest disclosure 2026-08-17). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: K Gary Barnette (1B/0S). Who is trading what
RapidTradeView pick record
VERU has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Veru Inc. (VERU) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell VERU.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.